Astellas begins phase 3 trials of fezolinetant in postmenopausal women with vasomotor symptoms

Children and adolescents (aged 6 to 17 years) living with type 1 diabetes achieved comparable reduction in average blood sugar (HbA1c) and similar risk of low blood sugar events with Toujeo (insulin glargine 300

Takeda has unveiled new data from its ongoing Phase 3 trial investigating the efficacy of its vaccine candidate TAK-003 in the prevention of the mosquito-borne virus dengue, confirming its ability to convey protection...

A clinical trial of Novartis’s Cosentyx drug has failed to prove it is significantly better than a rival treatment for a type of arthritis, the Swiss company said on Friday.